https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/dubowitz-neuromuscular-centre-confirmed-centre-paediatric-clinical-and-research-excellence/
Dubowitz Neuromuscular Centre confirmed as Centre of Paediatric Clinical and Research Excellence
22 Mar 2016, 3:37 p.m.
The Dubowitz Neuromuscular Centre has been confirmed as a Centre of Paediatric Clinical and Research Excellence by Muscular Dystrophy UK. The centre, based at Great Ormond Street Hospital and the UCL Institute of Child Health (ICH), is one of only ten Centres of Excellence and is the sole Paediatric Centre of Clinical and Research Excellence. This award recognises centres with outstanding levels of specialist care for people living with muscle wasting conditions.
The Dubowitz Neuromuscular Centre is a leading clinical- and research centre specialising in neuromuscular disorders affecting children. The centre provides clinical assessments, diagnostic services, and advice on treatment and rehabilitation alongside clinical trials and basic research focusing on causes of neuromuscular diseases in childhood and identifying new therapeutic interventions. The status was awarded following a national audit carried out by Muscular Dystrophy UK, aimed at ensuring that high-quality care is provided to patients with muscle-wasting conditions.
Great Ormond Street BRC Theme Lead, Professor Francesco Muntoni, is Head of the Dubowitz Neuromuscular Centre, and also leads the Novel Therapies for Translation in Childhood Diseases and the Developmental Neuroscience Programme at the ICH. He is co-director of the MRC Centre for Neuromuscular Diseases at UCL.
NIHR launches £13.7m investment into brain tumour research
The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
New consortium aims to help improve care for arthritis patients
A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly
Update for patients and families on industrial action - December 2025
As you may be aware, some of our Resident Doctors will be taking part in planned industrial action from 7am on Wednesday 17 December to 7am on Monday 22 December.
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia
A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer